At older ages, the potential role of adiponectin and nitric oxide (NO) was reported in many pathological disorders such as cognitive decline, fatigue, diabetes, obesity, inflammation, and physical activity status [28–30, 35, 36]. Here, ADIPOQ is linked to obesity disorder.